Petros E,Apostolos K,Peter H,Kavita R,Ramakrishna G S,Priscila N. .2021 .Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum, 06(4) : 858-74.
Bella YM,Said I,William B,Petros E.,Racial E. .2019 ./Ethnic variations in morbidity and mortality in adult onset still's disease: An analysis of national dataset. Semin Arthritis Rheum, 04(3) : 469-73.
Manuel RC,Pilar BZ,Armando LG,Munther AK,Xavier B .2014 .Adult haemophagocytic syndrome. Lancet, 6736(13) : 61048-X.
Fukaya S,Yasuda S,Hashimoto T,Oku K,Kataoka H,T Horita H .2008 .Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: Analysis of 30 cases. , 10(11) : 1686-91.
Ahn SS,Yoo BW,Jung SM,Lee SW,Park YB,Song JJ .2017 .Application of the 2016 EULAR/ACR/PRINTO classi cation criteria for macrophage activation syndrome in patients with adultonset still disease. J Rheumatol, 10(7) : 996-1003.
Yamaguchi M,Ohta A,Tsunematsu T,Kasukawa R,Mizushima Y,Kashiwagi H .1992 .Preliminary criteria for classi cation of adult Still's disease. J Rheumatol, 19(3) : 424-30.
Jan-Inge H,Annacarin H,Maurizio A,R Maarten E,Alexandra HF,Shinsaku I .2007 .-2004: Diagnostic and therapeutic guidelines for hemophagocytic lympho-histiocytosis. Pediatr Blood Cancer, 10(2) : 124-31.
Pouchot J,Sampalis JS,Beaudet B,Carette S,Decary F,Salusinsky-Sternbach M .1991 .Adult Still's disease: Manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore), 70(2) : 118-36.
Alexei AG,Horne AC,Benedetti FD .2015 .Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol, 179(5) : 259-68.
Yang XP,Wang M,Li TF,Li W,Zhang L,Liu SY .2019 .Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset still's disease. Clin Exp Rheumatol, 121(6) : 83-8.
Ruscitti P,Iacono D,Ciccia F,Emmi G,Cipriani P,Grembiale RD .2018 .Macrophage activation syndrome in patients a ected by adult-onset still disease: Analysis of survival rates and predictive factors in the gruppo Italiano di ricerca in reumatologia clinica e sperimentale cohort. J Rheumatol, 10(6) : 864-72.
Bae CB,Jung JY,Kim HA,Suh CH .2015 .Reactive hemophagocytic syndrome in adult-onset Still disease: Clinical features, predictive factors, and prognosis in 21 patients. Medicine (Baltimore), 10(4) : 00000000-00000451.
Wakabayashi K,Inokuma S,Matsubara E,Onishi K,Asashima H,Nakachi S .2013 .Serum ²2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease. Clin Rheumatol, 10(7) : 013-1005.
de Jager CP,Wijk PT,Mathoera RB,de Jongh-Leuvenink J,van der Poll T,Wever PC .2020 .Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care, 10(5) : .
Jin QW,Fu LJ,Yang HX,Chen XX,Lin S,Huang ZG .2023 .Peripheral lymphocyte count de nes the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis. J Intern Med, 10(4) : 494-507.
Maouia A,Rebetz J,Kapur R,Semple JW .2020 .The immune nature of platelets revisited. Transfus. Med Rev, 09(4) : 209-20.
Cho JC,Liang S,Lim SHH,Lateef A,Tay SH,Mak A .2022 .Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio re ect disease activity and ares in patients with systemic lupus erythematosus-A prospective study. Joint Bone Spine, 105342(4) : 105342.
Li MQ,Yan SY,Dong RR,Xiang WZ,Ma ZZ,Yang QR .2023 .Elevated platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with polymyositis/ dermatomyositis: A retrospective study. Clin Rheumatol, 10(6) : 1615-24.
Karima DA,Nadia AH,Fi O,Cha a DM,Farida M,Mohamed M .2022 .Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still's disease: A STROBE-Compliant prospective observational study. Medicine (Baltimore), 10(32) : .
Co ernils M,Soupart A,Pradier O,Feremans W,Neve P,Decaux G. .1992 .Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome. J Rheumatol, 19(9) : 1425-7.
Piero R,Francesco U,Onorina B,Francesco M,Bozzalla CE,Susanna N .2022 .Cytokine pro le, ferritin and multivisceral involvement characterise macrophage activation syndrome during adult-onset Still's disease. Rheumatology (Oxford), 10(1) : 321-9.
Piero R,Paola C,Francesco M,Daniela I,Francesco C,Vasiliki L .2016 .Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers. BMC Med, 10(1) : 194.
Piero R,Carmela R,Luciana B,Paola C,Vasiliki L,Onorina B .2017 .Macrophage activation syndrome in Still's disease: Analysis of clinical characteristics and survival in paediatric and adult patients. Clin Rheumatol, 10(12) : 2839-45.